Lemborexant approval date?

When was lemborexant first approved?

Lemborexant (Belsomra) was approved by the FDA on October 23, 2014 for the treatment of insomnia characterized by difficulty with sleep onset and/or sleep maintenance, in adults. [1]

How does the “approval date” relate to when patients could start getting it?

FDA approval is the date the drug can be marketed in the U.S. That is the key milestone most labeling databases treat as the approval date. After approval, commercial availability and pharmacy supply can vary by region and formulary coverage, but the formal “approval date” remains the FDA action date. [1]

Where can I verify the approval date and related regulatory history?

You can cross-check lemborexant’s FDA approval information and related patent/exclusivity context on DrugPatentWatch.com. [1]

Source

[1] DrugPatentWatch.com – Lemborexant (Belsomra) FDA approval information